|
Status |
Public on Jun 01, 2010 |
Title |
STZ 4 |
Sample type |
RNA |
|
|
Source name |
Retina, STZ
|
Organism |
Rattus norvegicus |
Characteristics |
strain: Sprague-Dawley gender: male tissue: retina treatment: streptozotocin (STZ)
|
Treatment protocol |
Diabetes was induced in Sprague-Dawley male rats (Charles River Laboratories, Wilmington, MA) by intraperitoneal injection of 65 mg/kg streptozotocin (STZ) (Sigma-Aldrich, St. Louis, MO) in 10mM sodium citrate pH 4.5 vehicle. Control rats were injected with an equal dose of vehicle only.
|
Growth protocol |
Rats had free access to food and water, and were maintained on a 12 hour light/dark cycle.
|
Extracted molecule |
total RNA |
Extraction protocol |
RNA was extracted with Trizol reagent, followed by clean-up and DNase I treatment with QIAGEN RNeasy mini kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
|
Label |
biotin
|
Label protocol |
Biotinylated cRNA were prepared with the Ambion TotalPrep kit for Illumina arrays.
|
|
|
Hybridization protocol |
Standard Illumina hybridization protocol. Cy3-Streptavidin was incorporated during the Wash and Block protocol as a fluor for scanning.
|
Scan protocol |
Standard Illumina scanning protocol.
|
Description |
Diabetes was induced by intraperitoneal injection of STZ. Replicate 4 of 4. 1685398124_I
|
Data processing |
The data were normalized using quantile normalization in GenomeStudio v1.0.6.
|
|
|
Submission date |
Mar 15, 2010 |
Last update date |
Apr 21, 2010 |
Contact name |
Penn State COM |
Organization name |
Penn State College of Medicine
|
Department |
Genome Sciences Facility
|
Street address |
500 University Drive
|
City |
Hershey |
State/province |
PA |
ZIP/Postal code |
17033 |
Country |
USA |
|
|
Platform ID |
GPL8031 |
Series (1) |
GSE20886 |
Multi-modal proteomic target discovery and orthogonol confirmation of preclinical diabetic retinopathy drug development biomarkers |
|